These novel treatments, Retatrutide, represent a groundbreaking advancement in treating type 2 diabetes and potentially other disorders. They are grouped as GLP-1 pathway agonists , signifying they function to emulate the natural GLP-1 hormone , boosting metabolic secretion and reducing hunger . While Retatrutide each one functions somewhat similar